Mesothelioma Treatments - Multimodal Treatment
Doctors specializing in mesothelioma treatment frequently adopt a multimodal approach: they treat a patient with a combination of therapies. Due to the relative lack of effectiveness of single-modality treatment in affecting patient survival, the multimodal combination of treatments holds more promise for survival of malignant mesothelioma patients. For an over view of single-mode and multimodal treatment regimens, see the abstract of "Treatment of Malignant Mesothelioma" by M.T. Jaklitsch, S.C. Grondin, and D.J. Sugarbaker and published in the World Journal of Surgery in 2001.
Mesothelioma treatments: drugs, chemotherapy, radiation and surgery treatments. on specific forms of malignant treatments and the most powerful against cancer, or any terminal and promising new treatments for malignant mesothelioma. Complementary and alternative forms of for patients with cancer, cancer resource, provides comprehensive on cancer treatments about treatment, including surgery, chemotherapy, radiation Treatments: Multimodeal treatment.
Multimodal therapy involves using more than one therapy to treat the symptoms or causes of mesothelioma. Often the weaknesses in one treatment can be compensated by the strengths of another, or one can boost the effectiveness and compliment a different approach.
Is this treatment more effective?
Many previous treatments for cancers such as mesothelioma have involved multimodal approaches. For instance, radiation therapy is rarely used alone, but rather in conjunction with chemotherapy and sometimes even surgery. This multi-pronged attack on the cancerous growth ensures that if one therapy does not quite eliminate the malignancy then the two other therapies will cover what the first one missed.
Multimodal therapy Side effects.
The unfortunate side effects of these elaborate treatments are their side effects; most anti-cancer agents destroy a percentage of healthy cells as well, and three times as many treatments destroy three times as many healthy cells. Multimodal treatments are therefore usually reserved for only the most aggressive or malignant cancers, such as mesothelioma.
